Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

All-cause mortality in young women with endometrial cancer receiving progesterone therapy.

Ruiz MP, Huang Y, Hou JY, Tergas AI, Burke WM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2017 Dec;217(6):669.e1-669.e13. doi: 10.1016/j.ajog.2017.08.007. Epub 2017 Aug 24.

PMID:
28844824
2.

Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?

Greenwald ZR, Huang LN, Wissing MD, Franco EL, Gotlieb WH.

Cancer. 2017 May 1;123(9):1545-1554. doi: 10.1002/cncr.30529. Epub 2016 Dec 27.

3.

Racial disparities in young women with endometrial cancer.

Mukerji B, Baptiste C, Chen L, Tergas AI, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Gynecol Oncol. 2018 Mar;148(3):527-534. doi: 10.1016/j.ygyno.2017.12.032. Epub 2018 Jan 5.

PMID:
29307452
4.

Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.

Bregar AJ, Alejandro Rauh-Hain J, Spencer R, Clemmer JT, Schorge JO, Rice LW, Del Carmen MG.

Gynecol Oncol. 2017 Apr;145(1):114-121. doi: 10.1016/j.ygyno.2017.01.024. Epub 2017 Feb 1.

PMID:
28159409
5.

Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer.

Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD.

Obstet Gynecol. 2016 Oct;128(4):761-70. doi: 10.1097/AOG.0000000000001647.

PMID:
27607873
6.

Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.

Matsuo K, Machida H, Takiuchi T, Garcia-Sayre J, Yessaian AA, Roman LD.

Gynecol Oncol. 2017 Apr;145(1):41-49. doi: 10.1016/j.ygyno.2017.02.004. Epub 2017 Feb 17.

PMID:
28215841
7.

Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK.

Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi: 10.1016/j.ajog.2016.07.035. Epub 2016 Jul 22.

8.

Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer.

Wright JD, Jorge S, Tergas AI, Hou JY, Burke WM, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2016 Jan;127(1):101-8. doi: 10.1097/AOG.0000000000001181.

9.

Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.

Rydzewski NR, Strohl AE, Donnelly ED, Kanis MJ, Lurain JR, Nieves-Neira W, Strauss JB.

Cancer. 2016 Dec 1;122(23):3724-3731. doi: 10.1002/cncr.30228. Epub 2016 Aug 10.

10.

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S, Massey C, Ferguson SE.

Gynecol Oncol. 2014 May;133(2):229-33. doi: 10.1016/j.ygyno.2014.02.020. Epub 2014 Feb 19.

PMID:
24561246
11.

Overuse of external beam radiotherapy for stage I endometrial cancer.

Wright JD, Margolis B, Hou JY, Burke WM, Tergas AI, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL.

Am J Obstet Gynecol. 2016 Jul;215(1):75.e1-7. doi: 10.1016/j.ajog.2016.02.007. Epub 2016 Feb 11.

12.

The Safety of Ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching.

Hou T, Sun Y, Li J, Liu C, Wang Z, Li Y, Lu Y.

Comb Chem High Throughput Screen. 2017;20(7):647-655. doi: 10.2174/1386207320666170417145856.

PMID:
28413975
13.

Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).

Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DS, Nam JH.

Eur J Cancer. 2013 Mar;49(4):868-74. doi: 10.1016/j.ejca.2012.09.017. Epub 2012 Oct 13.

PMID:
23072814
14.

Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer.

Wright JD, Huang Y, Burke WM, Tergas AI, Hou JY, Hu JC, Neugut AI, Ananth CV, Hershman DL.

Obstet Gynecol. 2016 Jan;127(1):109-18. doi: 10.1097/AOG.0000000000001194.

15.

Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.

Lajer H, Elnegaard S, Christensen RD, Ortoft G, Schledermann DE, Mogensen O.

Acta Obstet Gynecol Scand. 2012 Aug;91(8):976-82. doi: 10.1111/j.1600-0412.2012.01438.x. Epub 2012 Jun 18.

PMID:
22548255
17.

Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.

Laurelli G, Falcone F, Scaffa C, Messalli EM, Del Giudice M, Losito S, Greggi S.

Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:61-6. doi: 10.1016/j.ejogrb.2015.09.041. Epub 2015 Oct 8. Review.

PMID:
26476800
18.

Stage IIIA endometrial carcinoma: outcome and predictors of survival.

Bansal S, Buck AM, Herzog TJ, Deutsch I, Burke WM, Wright JD.

Obstet Gynecol. 2009 Jul;114(1):100-5. doi: 10.1097/AOG.0b013e3181a94568.

PMID:
19546765
19.

Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery.

Koskas M, Bendifallah S, Luton D, Daraï E, Rouzier R.

Fertil Steril. 2012 Nov;98(5):1229-35. doi: 10.1016/j.fertnstert.2012.07.1142. Epub 2012 Sep 6.

PMID:
22959452
20.

Significance of uterine corpus tumor invasion in early-stage cervical cancer.

Matsuo K, Machida H, Blake EA, Takiuchi T, Mikami M, Roman LD.

Eur J Surg Oncol. 2017 Apr;43(4):725-734. doi: 10.1016/j.ejso.2017.01.017. Epub 2017 Feb 3.

PMID:
28215507

Supplemental Content

Support Center